The Role of CD19 and CD27 in the Diagnosis of Multiple Myeloma by Flow Cytometry-Reference-Cited by-同舟云学术

The Role of CD19 and CD27 in the Diagnosis of Multiple Myeloma by Flow Cytometry

Published:2012-03 Issue:3 Volume:137 Page:377-386
ISSN:0002-9173
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:Am J Clin Pathol

Author:

Cannizzo Elisa,Carulli Giovanni,Del Vecchio Luigi,Ottaviano Virginia,Bellio Emanuele,Zenari Ezio,Azzarà Antonio,Petrini Mario,Preffer Frederic

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/137/3/377/18134235/ajcpath137-0377.pdf

Reference49 articles.

1. Munker R Hiller E Glass J eds. Modern Hematology: Biology and Clinical Management 2nd ed. Totowa, NJ: Humana Press; 2007:250.

2. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders

3. Bataille R Robillard N Avet-Loiseau H CD221 (IGF-1R) is aberrantly expressed in multiple myeloma, in relation to disease severity. Haematologica. 2005;90:706–707.

4. CD200 is a new prognostic factor in multiple myeloma

5. Phenotypic characterization of the human myeloma cell growth fraction

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunophenotypic Expression and its Association with Prognostic Factors, Clinical Stages, and Clinical Profiles in Newly Diagnosed Patients with Plasma Cell Myeloma: Insights from Two Tertiary Care Centers;Biomedical Research and Therapy;2024-03-31

2. Identification of mutation gene prognostic biomarker in multiple myeloma through gene panel exome sequencing and transcriptome analysis in Chinese population;Computers in Biology and Medicine;2023-09

3. Plasma Cell Leukemia—Clinicopathological Profile from a Tertiary Care Center in Western India;South Asian Journal of Cancer;2023-06-09

4. Immune microenvironment characteristics in multiple myeloma progression from transcriptome profiling;Frontiers in Oncology;2022-08-12

5. Histamine receptor 2 blockade selectively impacts B and T cells in healthy subjects;Scientific Reports;2021-04-30